Navigation Links
Joseph E. Whitters Joins MyoScience, Inc. Board of Directors
Date:6/25/2009

REDWOOD CITY, Calif., June 25 /PRNewswire/ -- MyoScience(R), Inc. today announced that Joseph E. Whitters, CPA former chairman of the board of Mentor Corporation, was elected to the MyoScience board of directors. Whitters joined the Mentor board in 2004, assuming the Chairman role soon thereafter. Mentor was acquired by Johnson and Johnson (JNJ) in 2009 for $1.1 Billion. He also serves on the boards of directors of Omnicell, Luminent Mortgage Capital, and several private companies. From 1986 to 2005, Mr. Whitters was an executive at First Health, serving as CFO for most of his tenure. During that period the company's revenues grew from $5 to $900 Million. It was acquired by Coventry Health Plans in 2005 for $1.8 Billion.

"Joe Whitters has an exceptionally strong financial and operational background. Additionally, he has a deep industry experience in the health care and aesthetics areas. This very relevant experience and his critical insight into the aesthetics market will greatly benefit a company at MyoScience's stage," said Bob Curtis, MyoScience CEO.

"I believe MyoScience has some very innovative and unique aesthetics technologies," said Whitters. "I look forward to working with this dynamic team and the board."

Whitters will fill a board seat left vacant by the stepping down of Michael Partsch, CEO of Accelemed, Inc., who has been a board member since MyoScience's initial funding. Mr. Partsch will remain a board observer.

"MyoScience has made great strides since its initial funding," said Michael Partsch. "I am honored to have been part of that success as a board member and am very excited about the opportunity available to the Company".

"Mike Partsch has been a valuable board member since our A round of financing," said Bob Curtis. "We thank him for his seminal contributions to the early success of MyoScience."

About MyoScience, Inc.

MyoScience, Inc., founded in 2005 with headquarters in Redwood City, California, is a clinical development stage company focused on developing a non-toxic treatment for dynamic facial wrinkles (frown lines between the brows and forehead and crow's feet lines). MyoScience received 510k clearance from the U.S. Food and Drug Administration for its device in 2009 for a general indication. MyoScience is currently investigating applications in aesthetics. Major investors in MyoScience, include De Novo Ventures, Accuitive Medical Ventures, Nexus Medical Partners, Saratoga Ventures, and Medicis Capital GmbH.

    Press Contacts:
    Robert M. Curtis, President and CEO
    MyoScience, Inc.
    bcurtis@myoscience.com
    (650) 474-2600


'/>"/>
SOURCE MyoScience, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. DURECT Appoints Dr. Joseph Stauffer as Chief Medical Officer and Executive Vice President, Corporate Strategy
2. Dr. Joseph Sweere Receives Educator of the Year Award
3. St. Josephs Hospital and Medical Center Signs Agreement for Innovative Video Conferencing Use
4. Statement by Joseph A. Califano, Jr., Chairman and Founder, The National Center on Addiction and Substance Abuse at Columbia University and Former U.S. Secretary of Health, Education, and Welfare, on New Report by the National Association of Boards of Pha
5. Joseph C. Kolars, M.D., to be U-M Medical Schools First Senior Associate Dean for Education and Global Initiatives
6. St. Josephs Healthcare System Becomes First Hospital in the Region to Implement Pre-Hospital Therapeutic Cooling to Save the Lives of Cardiac Arrest Patients
7. Statement by Joseph A. Califano, Jr., Chairman and President, The National Center on Addiction and Substance Abuse at Columbia University and Former U.S. Secretary of Health, Education and Welfare on New York States Action Council
8. Craneware and St. Joseph to Present Revenue Enhancement Success Story at HIMSS
9. Closing Open Heart Surgery: Saint Josephs Performs Georgias First Totally-Closed, Beating Heart Bypass Surgery
10. Transcept Pharmaceuticals Appoints Joseph T. Kennedy as General Counsel
11. Fischer Medical Announces Multi-System VersaRad Installation at St. Josephs Hospital in Marshfield, WI
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the ... In terms of the latter, setting the bar too high can result in disappointment, ... just slow progress toward their goal. , Research from PsychTests.com reveals ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, ... at his family verbally and physically. , “When something upset him, he couldn’t control his ... it. He would throw rocks at my other children and say he was going to ...
(Date:6/24/2016)... Diego, CA (PRWEB) , ... June 24, 2016 , ... ... with the American Cancer Society and the Road To Recovery® program to drive cancer ... to seniors and other adults to ensure the highest quality of life and ongoing ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... to recognize Dr. Barry M. Weintraub as a prominent plastic surgeon and the ... in the world, and the most handsome men, look naturally attractive. Plastic surgery ...
(Date:6/24/2016)... ... ... Venture Construction Group (VCG) sponsors Luke’s Wings 5th Annual ... Country Club at 1201 Rockville Pike, Rockville, Maryland, 20852. The event raised funds ... been wounded in battle and their families. Venture Construction Group is a 2016 Silver ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... CLEMENTE, Calif. , June 24, 2016  American Respiratory Labs ... company, is now able to perform sophisticated lung assessments in patients, ... Technologies , Inc. Patients are no longer limited ... ndd,s EasyOne PRO ® , ARL patients like Jeanne R. of ... done in the comfort of her own home. ...
(Date:6/24/2016)... LEXINGTON, Mass. , June 24, 2016   ... specialty pharmaceutical company developing innovative inhaled drugs, announced today ... when Russell Investments reconstituted its comprehensive set ... 2016. "This is an important milestone for ... "It will increase shareholder awareness of our progress in ...
(Date:6/23/2016)... -- MedSource announced today that it has selected Datatrial,s ... choice.  This latest decision demonstrates MedSource,s commitment to ... by offering a state-of-the-art electronic data capture (EDC) ... the EDC platform of choice in exchange for ... long been a preferred EDC platform by our ...
Breaking Medicine Technology: